Vanguard Personalized Indexing Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.76M	Buy	12,633 +660	+6%	+$505K	0.1%	178
2025 Q4	$9.24M	Buy	11,973 +901	+8%	+$612K	0.09%	178
2025 Q3	$6.23M	Buy	11,072 +219	+2%	+$124K	0.06%	260
2025 Q2	$5.7M	Buy	10,853 +792	+8%	+$442K	0.06%	261
2025 Q1	$6.38M	Sell	10,061 -130	-1%	-$89.4K	0.09%	185
2024 Q4	$7.26M	Sell	10,191 -414	-4%	-$347K	0.11%	154
2024 Q3	$11.1M	Buy	10,605 +1,046	+11%	+$1.16M	0.18%	95
2024 Q2	$10M	Buy	9,559 +1,129	+13%	+$1.09M	0.19%	87
2024 Q1	$8.11M	Buy	8,430 +386	+5%	+$367K	0.17%	95
2023 Q4	$7.06M	Buy	8,044 +75	+0.9%	+$61.8K	0.18%	96
2023 Q3	$6.56M	Buy	7,969 +810	+11%	+$637K	0.2%	82
2023 Q2	$5.14M	Buy	7,159 +253	+4%	+$195K	0.16%	104
2023 Q1	$5.67M	Buy	6,906 +560	+9%	+$422K	0.2%	92
2022 Q4	$4.58M	Buy	6,346 +152	+2%	+$112K	0.19%	100
2022 Q3	$4.27M	Buy	6,194 +966	+18%	+$608K	0.19%	88
2022 Q2	$3.09M	Buy	5,228 +1,281	+32%	+$833K	0.14%	126
2022 Q1	$2.76M	Buy	3,947 +1,166	+42%	+$738K	0.13%	134
2021 Q4	$1.76M	Buy	2,781 +441	+19%	+$271K	0.1%	196
2021 Q3	$1.42M	Buy	2,340 +461	+25%	+$286K	0.13%	157
2021 Q2	$1.05M	Buy	1,879 +667	+55%	+$338K	0.11%	187
2021 Q1	$573K	Buy	1,212 +16	+1%	+$7.79K	0.09%	281
2020 Q4	$578K	Sell	1,196 -48	-4%	-$25.9K	0.13%	189
2020 Q3	$696K	Buy	1,244 +144	+13%	+$87.3K	0.2%	125
2020 Q2	$686K	Buy	1,100 +59	+6%	+$33.5K	0.31%	74
2020 Q1	$508K	Buy	+1,041	New	+$429K	0.3%	93